Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Rheumatology 3, 64 (1 February 2007) | doi:10.1038/ncprheum0383
Long-term versus short-term doxycycline for C. trachomatis-reactive arthritis
Abstract
Putschky N et al. (2006) Comparing 10-day and 4-month doxycycline courses for the treatment of Chlamydia trachomatis-reactive arthritis: a prospective, double-blind trial. Ann Rheum Dis 65: 1521–1524 Urogenital infection with Chlamydia trachomatis is a major cause of reactive arthritis.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
